key: cord-0989685-r9tavsl0 authors: Wu, Yong‐Lin; Xu, Jun; Rong, Xing‐Yu; Wang, Feifei; Wang, Hui‐Jing; Zhao, Chao title: Gut microbiota alterations and health status in aging adults: From correlation to causation date: 2021-06-24 journal: Aging Med (Milton) DOI: 10.1002/agm2.12167 sha: 0f5ea0cf8b1cf4b139be6240c2387b1024df2538 doc_id: 989685 cord_uid: r9tavsl0 The deterioration of tissue structure and decline in physiological function during aging are accompanied by alterations to the gut microbiota. The elderly has higher risks of various diseases and chronic diseases. However, inter‐individual differences are more apparent in elderly than younger, and a proportion of individuals have a delayed onset or even avoid developing chronic diseases. This difference in health status is influenced by both heredity and Lifestyle and environmental factors. During the process of aging, the gut microbiota is also affected by the external environment, and provides a buffer to external challenge, and thus the gut microbiota reflects an individual's personal experience. Moreover, the immune system undergoes a series of changes with age, which are related to chronic inflammation in the elderly. The formation, maturation and senescence of the intestinal immune system is closely related to the gut microbiota. Additionally, changes in the gut microbiota of elderly individuals may modulate the immune system, which may in turn affect health status. Herein, we summarize the correlations between the gut microbiota with individual health status in the elderly and explore the related mechanisms, which may provide a basis to maintain or enhance the health of the elderly though interventions targeting the gut microbiota. Healthy aging involves reducing and delaying age-related morbidity. Fortunately, not all elderly individuals are fragile, and some have the ability to delay or even avoid chronic disease. The incidence of multiple chronic diseases increases with age, which can lead to the accumulation and coexistence of multiple diseases and elevate the risk of all types of diseases among elderly individuals. 1 The deterioration of tissue structure and the decrease of physiological function with aging play an essential role in age-related morbidity. 2 Moreover, aging is related to the accumulation of genetic and epigenetic modifications that limit the body's ability to maintain homeostasis and respond to external changes and challenges. 3 An individual's current health status is not only genetically determined, but also a reflection of their past experiences, such as exposure to various stresses, good or bad lifestyle habits, mental and physical challenges and environmental factors. Thus, the health status of elderly individuals can vary widely. Aging and health status affect a number of biological indices that could potentially be evaluated as indicators of individual health status. For example, the human microbiota is a promising indictor of health status that correlates with both internal and external effects on the body. The composition of the gut microbiota is not fixed, and can be affected by several factors, including diet, lifestyle, infection, activation of the immune response and the level of IgA produced by B cells. 4 The taxonomic composition of the gut microbiota varies among elderly individuals, and reflects current and previous health status. However, the microbiota can also act as a buffer against external damage and coordinate the health of the body. 5 Therefore, the human microbiota may reflect the health status of the organism during the aging process, and also may defend against damage. Additionally, the microbiota may affect the immune system function of the elderly, consequently modulating body biological regulatory network. Herein, we attempt to find answers to age-related disease states in terms of the microbiome and the resulting immune status. The correlation between them could give us a series of potential biomarkers for the early diagnosis, and for the prediction of the prognosis of the aging-related diseases. Meanwhile, the causation between them might be valuable targets for the interventions to the diseases ( Figure 1 ). Early studies by Jeffery et al revealed that the gut microbiota change with age. 4 Aging-associated changes in the gut microbiota were reported to manifest as an increase in pro-inflammatory symbionts and a decrease in beneficial microorganisms, 6 while another study did not find significant differences in the microbiota composition of healthy young adults and healthy aged adults from the same population. 7 However, a recent analysis of the microbiota cohort of healthy individuals using GWAS provided a statistical model. This model could predict the age of the human host from their gut microbiota and clearly showed that the microbiota changes with age. 8 In general, changes in the structure of the gut microbiota reflect changes in intestinal function and host metabolism. 9 Thirty-nine of 95 species of gut microbiota have been shown to play a crucial role in predicting age. A study in Ireland showed that Bacteroidetes species and the Firmicutes phylum predominate in the gut microbiota of elderly individuals. 4 Compared to younger individuals, the relative proportion of Bacteroides spp. was higher and the relative abundance of Clostridium groups was increased in the gut microbiota of elderly individuals. Older individuals also showed a reduction in the abundance of Ruminococcus, Prevotella F I G U R E 1 A possible network that connects external challenges, the immune system and diverse health status diversity to the GI microbiome during the aging process and related genera. 4 Bacteroidetes account for more than half (53%) of the core microbiota in elderly individuals, compared with 8%-27% in healthy young adults. The gut microbiota of elderly individuals contained a wide array of Bacteroides, Alistipes and Parabacteroides species, while that of healthy young adults also contained a unique Bacteroides species, most similar to Bacteroides vulgatus. Moreover, when the aggregated microbiota was compared, cluster IV was most predominant cluster among the elderly group, whereas cluster XIVa was more prevalent in the healthy young cohort. Gut microbiota senescence has been related to external factors, such as alcohol, antibiotics, probiotics, or diet. 8 Thus, the accumulation of external effects may possibly explain the altered gut microbiota diversity in the elderly. The microbiota is also affected by the outside environment at in the gut microbiota of infants and young children. 11 By the age of three, the diet becomes more diverse, and the microbiota gradually transform into an adult-like form. 10 A core microbiota is shared between puberty and adulthood. 12 The gut microbiota of adults is quite stable, and also more flexible and complex, and can buffer exogenous invasions such as stress. However, the gut microbiota of adults can still be altered by environmental disturbances. 13 A recent study showed that even short-term exposure to diets consisting entirely of animal or plant products significantly change the structure of the adult gut microbial community. 13 Therefore, interindividual variations in numerous factors can lead to differences in the gut microbiota both during early life and also in adults. Gut microbiota that can offset exogenous damage may accumulate the influence of these external factors through specific alternation, which may partially explain the greater diversity of the gut microbiota in the elderly. A recent study showed that the gut microbiota composition of Bacteroidetes phyla stimulate the inflammasome pathway in the intestine and lead to an inflammatory response. 15 Based on the changes in the gut microbiota of the elderly, an inflammatory response in the gut is likely to develop during ageing This age-related imbalance in the gut microbiota could reduce the integrity of the intestinal barrier. 6 Subsequent leakage of microbial products may upregulate the circulating levels of pro-inflammatory factors (such as interferons, TNFα, interleukin-6 and interleukin-1) and promote a persistent low-grade inflammatory state, which has been related to cognitive decline and dementia. 1 The persistent lowgrade inflammatory state has also been observed in other chronic diseases, such as IBD, 16, 17 diabetes type I, 18 CVD 19 and metabolic disorders. 20 The pro-inflammatory state caused by dysbiosis of the gut microbiota is considered to play key roles in these common diseases of the elderly. The effects of aging on the immune system are associated with significant inter-individual differences. 21 The gradual decline in immune function caused by aging leads to a reduction in adaptability and increase in vulnerability. 22 For example, disruptions to homeostasis of the host lead to increased morbidity and mortality in the elderly. 2,23 Moreover, aging is commonly thought to have a distinct effect on adaptive immunity in elderly individuals. In the innate immune system, neutrophils exhibit a sharp decline in bactericidal and phagocytic function as the cells age. 24 Macrophage function also changes, with increased secretion of IL-6 and IL-8 induced by mitogens and lipopolysaccharides. Dendritic cells also significantly reduce in number, distribution, and likelihood of production and development from hematopoietic precursors. 25 Natural killer cells also exhibit reduced cytotoxicity as the cells age. 26 In terms of the adaptive immune system, the thymus atrophies and the number of naive T cells decrease, while the proportion of memory T cells increase during aging. The number and proliferation of Th1 cells also decrease. Additionally, the number and proliferation of memory Th2 cells increases; which leads to production of higher levels of IL-10, which further inhibits the function of Th1 cells. The consequence is a decrease in Th1-type immunity mediated by cells. Moreover, the decrease in the production of antibodies by B cells in response to antigens is thought to be primarily due to the decline in helper T cell activates for B cells. 21 These alternations increase susceptibility to immune-mediated diseases. In addition, the increase in pro-inflammatory factors is characteristic of chronic inflammation, 27 which has been related to degenerative diseases such as diabetes and osteoporosis. 28 Neurons are active participants in the interaction between the central nervous system and the immune system, and regulate the activation of microglia to maintain the integrity of the central nervous system. 29 Aging can influence the interaction between microglia and neurons by altering the nervous environment, and results in increased microglial reactivity. 30 Compared with healthy microglial cells, aged microglia a more rapid induction and release the higher levels of cytokines upon activation. Primed microglia appear to be in an intermediate activation state with deamidation and upregulation of MHCII. 30 After further stimulation induced by activation of the peripheral or central innate immune system, primed or sensitized microglia releases pro-inflammatory cytokines significantly and for a long time. 31 It also shows significant enhancement of the proinflammatory cytokines IL-1β, IL-6, and TNFα after immune stimulation with the bacterial endotoxin lipopolysaccharide in vitro. 32 Also, the levels of the anti-inflammatory cytokines IL-10 and IL-4 decrease with age-related increases in the levels of the pro-inflammatory cytokines. 33 These changes have been linked to cognitive decline and depressive behavior. 34 Chronic inflammation and chronic diseases, such as diabetes and cancer are associated with aging. 35 The underlying inflammatory response increases with age, which in turn leads to chronic, low-grade inflammation that accelerates aging. 35 This process is known as "inflammaging", and is also a process of immunosenescence. 36 Various mechanisms are involved in inflammaging, such as the redox stress hypothesis, mitochondrial dysfunction, immunosenescence, chronic infection and homeostasis reconstruction. 37 Induction and maintenance of the intestinal mucosal immune response is a multi-step process. First, intestinal cavity antigens are transported across the intestinal epithelium. 38 In aging mice, the 43 However, the high-sensitivity immunohistochemical analysis of Peyer's knots in aged mice revealed that the apparent M-cellinducingCD11c + CD45R + (B220) cells in FAE was significantly reduced, 44 while the density of CD11c + MNP in the sub-epithelium dome (SED) was not adversely affected61. The ability of dendritic cells to initiate T cell responses appears to be impaired in old mice. 45 Another study also reported that aging dendritic cells are characterized by a significant decrease in IL-12p70 and IL-15 production, accompanied by a decrease in the expression of the CD80/CD86 co-stimulatory signal, and that the reduced IL-15 appears to reduce the ability to initiate T cell response of aging dendritic cells. 45 IgA was unchanged or even increased during aging. 46 However, the heterogeneity of the VH gene pool of IgA antibodies is increased in aged mice, and the affinity of IgA to antigen decreases. 49 A study published in 2019 showed that patients treated with broad-spectrum antibiotics before receiving immune checkpoint inhibitors (ICIs) for cancer treatment were nearly twice as likely to respond poorly to ICI than patient who were not treated with broad-spectrum antibiotics. Broad-spectrum antibiotics may lead to an imbalance in the gut microbiota that affects the treatment of cancer with ICIs. 50 Moreover, oral administration of broadspectrum antibiotics in mice reduced the severity of experimental autoimmune encephalomyelitis (EAE). 51 Single colonization of germ-free mice with segmented filamentous bacteria (SFB) enhanced the ability to recruit neutrophils and other immune cells of T helper 17 (Th17) cells in the intestinal lamina propria and the central nervous system, and caused severe EAE. Therefore, enhancement of Th17 cell-mediated inflammation by SFB may exacerbate EAE. 52 These studies indicate a possible mechanism by which the gut microbiota can promote the progression of aging related diseases by affecting the immune system. Comparison of germ-free and colonized mice revealed that colony colonization had a profound effect on the formation of lymphoid tissue and subsequent development of the immune system. 53 Thus, the microbiota affects the immune system. On one hand, the microbiota affects the development of myeloid cells. 54 The level of myeloid production is related to the complexity of the gut microbiota and mediated by the level of TLR ligands present in the serum. 55 Microbial-derived short-chain fatty acids (SCFA) can promote hematopoiesis in the bone marrow. 54 However, the signals produced by the microbiota do not seem to affect the lymphopoiesis of innate lymphoid cells (ILCs), as these cells develop normally in the absence of microbiota. 56 On the other hand, the microbiota affects the maturation and function of myeloid cells 56, 57 and innate lymphoid cells. 56, 57 The persistence of microbiota-derived TLR ligands drives neutrophil senescence 57 and affects the number of basophils in the circulation. 58 SCFAs such as acetate and propionate produced by Bacteroides fermented polysaccharides and butyrate produced by thick-walled fungi can promote the integrity and function of intestinal epithelium. 15, 59 SCFAs can also inhibit the production of proinflammatory cytokines by macrophages and neutrophils, 60 Changes in the gut microbiota may increase the expression of proinflammatory factors and lead to chronic age-related inflammation. inter-individual variations could be one mechanism underlying the inter-individual differences in immunosenescence. Thus, the gut microbiota may lead to the emergence of health diversity in the elderly. The relationship between gut microbiota and immune system in the elderly is illustrated in Figure 2 . Based on the premise that the health diversity of the elderly is related to changes and differences in the gut microbiota, a recent study showed that drug treatment inhibited the gut microbiota dysbiosis and improve neuroinflammation and reduced cognitive disorders in a mouse model of Alzheimer's disease. 14 In addition, transplantation of the microbiota from patients with Parkinson's disease increased motor dysfunction in a mouse model of Parkinson's mouse compared to transplantation of microbiota from healthy controls. 74 Thus, the gut microbiota may influence the aging process of the immune related network. Therefore, we believe that the alterations to the gut microbiota caused by the internal and external environment are key factor in age-related diseases. The alterations to the gut microbiota have shaped the differences in the health status of the elderly by affecting the human immune system for a long time. Thus, it is feasible that regulation of immune changes by modulating the gut microbiota may delay aging and improve the quality of life of the elderly. Elderly individuals are susceptible to a variety of chronic diseases, such as cognitive impairment, that represent a significant socioeconomic burden. Aging-related diseases are frequently associated with immunosenescence caused by chronic inflammation. The development of several age-related diseases is accompanied by age-related changes in the gut microbiota changes. The immune system also undergoes a series of changes during aging, which contribute to a chronic inflammatory state in the elderly. Aging has a significant effect on the intestinal immune system. The formation and maturation of the intestinal immune system is closely related to the gut microbiota. Therefore, changes in the gut microbiota in the elderly can affect the state of the immune system, and even accelerate immunosenescence. The occurrence of gut microbiota dysbiosis in parallel to immunosenescence may induce rapid progression of aging-related diseases. In conclusion, as a buffered medium of internal and external factors interaction, the gut microbiota provides a reflection of the internal state of the host, especially the immune state. Thus, the gut microbiota may represent an effective biomarker of health status. As proof of causality, the gut microbiota is involved in the mechanisms underlying aging-related diseases. Therefore, the gut microbiota can be explored as a target for intervention to improve the quality of life of the elderly and achieve the goal of healthy aging. Authors have no conflict of interest to declare. Wu Yong-Lin completed the collection and analysis of relevant literature and drafted the manuscript as the main writer of the review. Changes of the gut microbiota and intestinal mucosal immunity in aging hosts. Proposed mechanism by which aging of the intestinal mucosal immune system leads to gut microbiota dysregulation and immune cell dysfunction. The density and antigen crosspresentation of intestinal epithelial M cells decrease during aging, which leads to downregulation of antigen intake by dendritic cells and macrophages. Moreover, downregulation of antigen-presenting cell activated associated cytokines and the quantity of antigen-presenting cell restrained T cell activation, which reduces the secretion of cytokines, such as IFNγ. In turn, these changes reduce the affinity of IgA for antigen and increased the heterogenicity of IgA. In addition, gut microbiota dysregulation characterized by a decrease in beneficial microorganisms and increase in pro-inflammatory symbionts also occur in the aging host [Colour figure can be viewed at wileyonlinelibrary. com] Xu Jun, Rong Xing-Yu, Wang Feifei and Wang Hui-Jing participate in the analysis and sorting of literature materials. Zhao Chao is the architect of the concept, and the person in charge of the project and guides the writing of the paper. All authors have read and approved the content of the manuscript. https://orcid.org/0000-0001-7349-306X Gut microbiota as the key controllers of "healthy" aging of elderly people The biology of aging Cellular senescence, ageing and disease Composition and temporal stability of the gut microbiota in older persons Host-associated niche metabolism controls enteric infection through fine-tuning the regulation of type 3 secretion Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut The gut microbiota of healthy aged Chinese is similar to that of the healthy young Human microbiome aging clocks based on deep learning and tandem of permutation feature importance and accumulated local effects Has the microbiota played a critical role in the evolution of the adaptive immune system? The microbiome in early life: implications for health outcomes The bacterial microbiome and virome milestones of infant development Antibiotics, birth mode, and diet shape microbiome maturation during early life Diet rapidly and reproducibly alters the human gut microbiome Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acidsshaped neuroinflammation to inhibit Alzheimer's disease progression Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome Cytokines in inflammatory bowel disease Dysregulation of leukocyte trafficking in ageing: Causal factors and possible corrective therapies Type 1 diabetes mellitus: Complex interplay of oxidative stress, cytokines, gastrointestinal motility and small intestinal bacterial overgrowth Targeting inflammation in CVD: advances and challenges High-sensitivity C-reactive protein is associated with incident type 2 diabetes among African Americans: The Jackson heart study Host and environmental factors influencing individual human cytokine responses Author Correction: The twilight of immunity: emerging concepts in aging of the immune system The twilight of immunity: emerging concepts in aging of the immune system Evolution of the immune system in humans from infancy to old age Dendritic cells from bench to bedside and back Association between natural killer cell activity and infection in immunologically normal elderly people Inflammaging: a new immune-metabolic viewpoint for age-related diseases Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics Microglia function in the central nervous system during health and neurodegeneration Systemic infections and inflammation affect chronic neurodegeneration Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration Acute transient cognitive dysfunction and acute brain injury induced by systemic inflammation occur by dissociable IL-1-dependent mechanisms An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice Age-related cognitive impairment is associated with long-term neuroinflammation and oxidative stress in a mouse model of episodic systemic inflammation Geroscience: linking aging to chronic disease Biomarker signatures of aging Chronic inflammation: accelerator of biological aging Aging and the mucosal immune system in the intestine Age-related changes in small intestinal mucosa epithelium architecture and epithelial tight junction in rat models A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating personto-person transmission: a study of a family cluster Can DCs be distinguished from macrophages by molecular signatures? Lack of oral tolerance in aging is due to sequential loss of Peyer's patch cell interactions Distribution of mast cell subtypes and immune cell populations in canine intestines: evidence for age-related decline in T cells and macrophages and increase of IgA-positive plasma cells CCR6hiCD11c(int) B cells promote M-cell differentiation in Peyer's patch Aging mice exhibit a functional defect in mucosal dendritic cell response against an intracellular pathogen Aging correlates with reduction in regulatory-type cytokines and T cells in the gut mucosa TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo Intestinal lymphocyte number, migration and antibody secretion in young and old rats Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer Disrupting myelinspecific Th17 cell gut homing confers protection in an adoptive transfer experimental autoimmune encephalomyelitis Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice Gut microbiota promote hematopoiesis to control bacterial infection Microbiota-derived compounds drive steady-state granulopoiesis via MyD88/TICAM signaling The microbiome and innate immunity Neutrophil ageing is regulated by the microbiome Basophils activated via TLR signaling may contribute to pathophysiology of type 1 autoimmune pancreatitis Metabolites: messengers between the microbiota and the immune system Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis Microbiota-derived short chain fatty acids modulate microglia and promote Abeta plaque deposition B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived shortchain fatty acids Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells Microbiota-derived short-chain fatty acids promote the memory potential of antigenactivated CD8+ T cells Functional and phenotypic heterogeneity of group 3 innate lymphoid cells Pregnane X receptor activation attenuates inflammation-associated intestinal epithelial barrier dysfunction by inhibiting cytokine-induced myosin light-chain kinase expression and c-Jun N-terminal kinase 1/2 activation Bile acids and their receptors Interleukin-18: Biological properties and role in disease pathogenesis Emerging roles of bile acids in mucosal immunity and inflammation Extracellular ATP and adenosine: The Yin and Yang in immune responses? Understanding the holobiont: how microbial metabolites affect human health and shape the immune system Diet-microbiota interactions as moderators of human metabolism Heterochronic faecal transplantation boosts gut germinal centres in aged mice Gut Microbiota regulate motor deficits and neuroinflammation in a model of parkinson disease